ARTICLE | Clinical News
BNC105: Phase I/II started
June 4, 2012 7:00 AM UTC
Bionomics began an open-label, international Phase I/II trial to evaluate BNC105 in combination with gemcitabine in about 134 women with partially platinum-sensitive ovarian cancer with 1-2 relapses. ...